.ALX Oncology's phase 2 stomach cancer response price has diminished. After observing its CD47 block...
.One More of Ionis Pharmaceuticals' key midphase readouts has fallen short of desires, causing the b...
.While Biogen's pharma peers are seeking for late-stage possessions along with little risk, chief ex...
.Instil Biography has actually been a biotech looking for a pipe after it ditched its lead propertie...
.Biogen has actually returned civil liberties to a very early Alzheimer's health condition plan to D...
.Invite to this week's Chutes & Ladders, our roundup of significant leadership hirings, shootings...
.Tip's try to treat an unusual genetic disease has reached one more problem. The biotech threw two m...
.Vir Medical's second-quarter profits document had not been short of big information. The business w...
.Galapagos has stopped application in a test of a BCMA-directed CAR-T cell therapy, pumping the brak...
.After more than three decades, genetics therapy trendsetter James Wilson M.D., Ph.D., is actually l...